Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Utah Medical Products, Inc. (UTMD) Anymore

Page 1 of 2

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The time period between June 25 and the end of October was one of those periods, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 14 percentage points. Given that the funds we track tend to have a disproportionate amount of their portfolios in smaller cap stocks, they have seen some volatility in their portfolios too. Actually, their moves are potentially one of the factors that contributed to this volatility. In this article, we use our extensive database of hedge fund holdings to find out what the smart money thinks of Utah Medical Products, Inc. (NASDAQ:UTMD).

Is Utah Medical Products, Inc. (NASDAQ:UTMD) a buy, sell, or hold? Prominent investors are in a pessimistic mood. The number of bullish hedge fund positions inched down by 1 lately. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Genie Energy Ltd (NYSE:GNE), Hallador Energy Co (NASDAQ:HNRG), and DSP Group, Inc. (NASDAQ:DSPG) to gather more data points.

Follow Utah Medical Products Inc (NASDAQ:UTMD)
Trade (NASDAQ:UTMD) Now!

To most market participants, hedge funds are assumed to be unimportant, old financial vehicles of years past. While there are greater than 8000 funds trading at present, Our experts choose to focus on the upper echelon of this club, around 700 funds. These money managers orchestrate bulk of all hedge funds’ total capital, and by watching their top equity investments, Insider Monkey has brought to light various investment strategies that have historically exceeded the market. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, let’s view the latest action encompassing Utah Medical Products, Inc. (NASDAQ:UTMD).

What does the smart money think about Utah Medical Products, Inc. (NASDAQ:UTMD)?

Heading into Q4, a total of 4 of the hedge funds tracked by Insider Monkey were long this stock, a change of -20% from one quarter earlier. With hedge funds’ capital changing hands, there exists a select group of notable hedge fund managers who were increasing their holdings significantly (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Brian Bares, Russell Mollen, and James Bradshaw’s Nine Ten Partners has the most valuable position in Utah Medical Products, Inc. (NASDAQ:UTMD), worth close to $14.6 million, corresponding to 6.6% of its total 13F portfolio. The second most bullish fund manager is Jim Simons of Renaissance Technologies, with a $5.1 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Other professional money managers that are bullish include Chuck Royce’s Royce & Associates and Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!